Evidence map›Paper›PMID 39013604›Full record

ArticleTobacco control2025

IQOS news media coverage in Israel: a comparison across three subpopulations.

Amal Khayat, Yael Bar-Zeev, Yechiel Kaufman, Carla Berg, Lorien Abroms, Zongshuan Duan, Cassidy R LoParco, Yan Wang, Yuxian Cui, Hagai Levine

Abstract readComparative Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Tobacco control, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Amal KhayatBraun School of Public Health and Community Medicine, Hebrew University of Jerusalem Faculty of Medicine, Jerusalem, Israel amal.khayat@mail.huji.ac.il.ORCID 0000-0003-0525-4889
Yael Bar-ZeevBraun School of Public Health and Community Medicine, Hebrew University of Jerusalem Faculty of Medicine, Jerusalem, Israel.ORCID 0000-0002-1916-836X
Yechiel KaufmanBraun School of Public Health and Community Medicine, Hebrew University of Jerusalem Faculty of Medicine, Jerusalem, Israel.
Carla BergDepartment of Prevention and Community Health, The George Washington University Milken Institute of Public Health, Washington, District of Columbia, USA.ORCID 0000-0001-8931-1961
Lorien AbromsDepartment of Prevention and Community Health, The George Washington University Milken Institute of Public Health, Washington, District of Columbia, USA.ORCID 0000-0001-6859-283X
Zongshuan DuanDepartment of Population Health Sciences, Georgia State University, Atlanta, Georgia, USA.
Cassidy R LoParcoDepartment of Prevention and Community Health, The George Washington University Milken Institute of Public Health, Washington, District of Columbia, USA.
Yan WangDepartment of Prevention and Community Health, The George Washington University Milken Institute of Public Health, Washington, District of Columbia, USA.
Yuxian CuiDepartment of Prevention and Community Health, The George Washington University Milken Institute of Public Health, Washington, District of Columbia, USA.
Hagai LevineBraun School of Public Health and Community Medicine, Hebrew University of Jerusalem Faculty of Medicine, Jerusalem, Israel.ORCID 0000-0002-5597-4916

Funding

Assessing IQOS Marketing Influences and Consumer Behavior in Israel: Implications for the USR01CA239178 · NCI · GEORGE WASHINGTON UNIVERSITY · PI BERG, CARLA J, LEVINE, HAGAI · 2019 to 2021
$1.2M
NCI NIH HHS R01 CA239178
6 · The paper itself

Abstract

backgroundPhilip Morris International's (PMI) IQOS, a leading heated tobacco product globally, entered the Israeli market in 2016. IQOS and/or electronic cigarette use is higher in Israel's Arab population (2.8% vs 1.2% of Jews). However, previous research indicated possible targeting of the Ultra-orthodox Jewish population with more IQOS paid ads. This paper examined how IQOS is framed in news media articles directed at three subpopulations in Israel: Arab, Ultra-orthodox Jews and general public.

methodsMedia articles (January-October 2020) were obtained from Ifat media and were coded using abductive coding. Characteristics of articles (photo and article content) targeting each subpopulation were compared using χ

resultsOf the 63 unique articles identified, 16 targeted Arab, 24 Ultra-orthodox Jews and 23 general public. Arab and Ultra-orthodox Jewish media significantly differed from the general public's media in their positive framing of PMI (100% Arab and 75% Ultra-orthodox Jews vs 52% general public, p=0.004), and IQOS (100% Arab and 88% Ultra-orthodox Jews vs 61% general public, p=0.006). Arab media differed from others by highlighting IQOS' retail locations (81% vs 17% Ultra-orthodox Jews and 13% general public), social benefits (88% vs 8% Ultra-orthodox Jews and 17% general public) and reflecting content from PMI's press release (100% vs 46% Ultra-orthodox Jews and 35% general public; ps <0.001).

conclusionsIQOS was framed more positively in media targeting minority populations (Arab and Ultra-orthodox Jews), compared with general public. Arabic media in particular emphasised IQOS' retail accessibility and social benefits. These findings highlight the need for media surveillance and regulation, especially of minority-oriented media.

Indexed as

ArabsJewsMass MediaTobacco ProductsHumansIsraelAdvertising and PromotionMediaPublic policyTobacco industry

Identifiers

PMID39013604
PMCPMC11735691

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.